First new management for poisonous snakebites in more than 50 years is now available. Biotechnology product provides safe and effective therapy for poisonous snake bites.
D000997:Antivenins / Q000627:therapeutic use*; D006801:Humans; D007140:Immunoglobulin Fab Fragments; D007128:Immunoglobulin Fragments / Q000627:therapeutic use*; D012909:Snake Bites / Q000628:therapy*
D000997:Antivenins; C431183:Crotalidae Polyvalent immune Fab; D007140:Immunoglobulin Fab Fragments; D007128:Immunoglobulin Fragments